337 related articles for article (PubMed ID: 36473894)
21. Cutibacterium acnes phylogenetic type IC and II isolated from patients with non-acne diseases exhibit high-level biofilm formation.
Nakase K; Koizumi J; Midorikawa R; Yamasaki K; Tsutsui M; Aoki S; Nasu Y; Hirai Y; Nakaminami H; Noguchi N
Int J Med Microbiol; 2021 Oct; 311(7):151538. PubMed ID: 34649133
[TBL] [Abstract][Full Text] [Related]
22. Noninflammatory comedones have greater diversity in microbiome and are more prone to biofilm formation than inflammatory lesions of acne vulgaris.
Loss M; Thompson KG; Agostinho-Hunt A; James GA; Mongodin EF; Rosenthal I; Cheng N; Leung S; Chien AL; Kang S
Int J Dermatol; 2021 May; 60(5):589-596. PubMed ID: 33615460
[TBL] [Abstract][Full Text] [Related]
23. The increasing importance of the gut microbiome in acne vulgaris.
Siddiqui R; Makhlouf Z; Khan NA
Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study.
Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H
Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666
[TBL] [Abstract][Full Text] [Related]
25. Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes.
Keshari S; Kumar M; Balasubramaniam A; Chang TW; Tong Y; Huang CM
Expert Rev Vaccines; 2019 May; 18(5):433-437. PubMed ID: 30920859
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
28. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions.
Rimon A; Rakov C; Lerer V; Sheffer-Levi S; Oren SA; Shlomov T; Shasha L; Lubin R; Zubeidat K; Jaber N; Mujahed M; Wilensky A; Coppenhagen-Glazer S; Molho-Pessach V; Hazan R
Nat Commun; 2023 Feb; 14(1):1005. PubMed ID: 36813793
[TBL] [Abstract][Full Text] [Related]
29. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.
Kim YG; Lee JH; Park S; Lee J
Microbiol Spectr; 2022 Feb; 10(1):e0205621. PubMed ID: 35107361
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Biofilm-Forming Ability and Antibiotic Resistance of
Ruchiatan K; Rizqandaru T; Satjamanggala PR; Tache N; Cahyadi AI; Rezano A; Gunawan H; Sutedja EK; Dwiyana RF; Hidayah RMN; Achdiat PA; Sutedja E; Suwarsa O; Hindritiani R
Clin Cosmet Investig Dermatol; 2023; 16():2457-2465. PubMed ID: 37719934
[TBL] [Abstract][Full Text] [Related]
31. Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process.
Dagnelie MA; Corvec S; Saint-Jean M; Nguyen JM; Khammari A; Dréno B
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2340-2348. PubMed ID: 31299116
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the newly isolated phage Y3Z against multi-drug resistant Cutibacterium acnes.
Xuan G; Wang Y; Wang Y; Lin H; Wang C; Wang J
Microb Pathog; 2023 Jul; 180():106111. PubMed ID: 37084823
[TBL] [Abstract][Full Text] [Related]
33. The Microbiome and Acne: Perspectives for Treatment.
Dessinioti C; Katsambas A
Dermatol Ther (Heidelb); 2024 Jan; 14(1):31-44. PubMed ID: 38183614
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
[TBL] [Abstract][Full Text] [Related]
35. Evolution of the facial skin microbiome during puberty in normal and acne skin.
Schneider AM; Nolan ZT; Banerjee K; Paine AR; Cong Z; Gettle SL; Longenecker AL; Zhan X; Agak GW; Nelson AM
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):166-175. PubMed ID: 36165604
[TBL] [Abstract][Full Text] [Related]
36. Yin and Yang of skin microbiota in "swimmer acne".
Morss-Walton PC; McGee JS; Rosales Santillan M; Kimball R; Cukras A; Patwardhan SV; Porter ML; Kimball AB
Exp Dermatol; 2022 Jun; 31(6):899-905. PubMed ID: 35118730
[TBL] [Abstract][Full Text] [Related]
37. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions.
Kwon HH; Yoon JY; Park SY; Suh DH
Br J Dermatol; 2013 Nov; 169(5):1152-5. PubMed ID: 23795647
[TBL] [Abstract][Full Text] [Related]
38.
Spittaels KJ; Ongena R; Zouboulis CC; Crabbé A; Coenye T
Front Cell Infect Microbiol; 2020; 10():575164. PubMed ID: 33330124
[TBL] [Abstract][Full Text] [Related]
39. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study.
Jahns AC; Lundskog B; Ganceviciene R; Palmer RH; Golovleva I; Zouboulis CC; McDowell A; Patrick S; Alexeyev OA
Br J Dermatol; 2012 Jul; 167(1):50-8. PubMed ID: 22356121
[TBL] [Abstract][Full Text] [Related]
40. Multidrug Resistance Plasmid pTZC1 Could Be Pooled among
Koizumi J; Nakase K; Hayashi N; Takeo C; Nakaminami H
Microbiol Spectr; 2023 Feb; 11(2):e0362822. PubMed ID: 36847559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
